Results 251 to 260 of about 677,727 (291)
Some of the next articles are maybe not open access.
Rinsho byori. The Japanese journal of clinical pathology, 1997
Fabry disease is characterized by a deficiency of lysosomal alpha-galactosidase (alpha-Gal) and the accumulation of glycosphingolipid (e.g. predominantly globotriaosylceramide) in various tissues, mainly in lysosomes of the vascular endothelium. This disorder is currently classified into two clinical phenotypes; classical severe type and atypical ...
T, Okumiya +3 more
openaire +1 more source
Fabry disease is characterized by a deficiency of lysosomal alpha-galactosidase (alpha-Gal) and the accumulation of glycosphingolipid (e.g. predominantly globotriaosylceramide) in various tissues, mainly in lysosomes of the vascular endothelium. This disorder is currently classified into two clinical phenotypes; classical severe type and atypical ...
T, Okumiya +3 more
openaire +1 more source
Multidimensional computational strategies enhance the thermostability of alpha-galactosidase
International Journal of Biological MacromoleculesAlpha-Galactosidase has significant industrial application value in food processing, animal nutrition and medical applications. Microbial-derived α-galactosidases predominate industrial implementation due to high productivity, yet their inherent thermal instability necessitates systematic protein engineering.
Youfeng Zou +4 more
openaire +2 more sources
[Fabry disease (alpha-galactosidase deficiency)].
Nihon rinsho. Japanese journal of clinical medicine, 1996Fabry disease is an X-linked glycosphingolipid storage disorder resulting from a deficiency of lysosomal alpha-galactosidase (alpha-Gal; EC 3.2.1.22). Classical form patients, with clinical manifestations of generalized angiopathy of early onset, usually show no detectable alpha-Gal activity.
T, Okumiya, H, Sakuraba
openaire +1 more source
Studies with plant alpha-galactosidases
1976The two molecular forms, I and II, of [alpha]-galactosidase from immature, mature (resting) and germinated vicia faba seeds have been studied. The enzymes have been purified by a multistage procedure and, in particular, the effect these stages have upon the relative isoenzyme levels has been investigated.
openaire +1 more source
Structure-function relationships in alpha-galactosidase A.
Acta paediatrica (Oslo, Norway : 1992), 2007With recent interest in the molecular mechanisms responsible for Fabry disease, the number of known mutations in the GLA gene which encodes alpha-galactosidase A has expanded considerably. Combining a large database of Fabry disease-causing mutations with the recently determined crystal structure of human alpha-galactosidase A allows for a new ...
openaire +1 more source
A case of Fabry disease (alpha-galactosidase A deficiency).
The Journal of the Kentucky Medical Association, 1994Fabry disease is a rare lipid storage disorder, often silent until adulthood. We report the case of a rural, primary care patient whose initial presentation was that of progressive weakness from anemia. The anemia was determined to be of renal origin, and led to a diagnosis of Fabry disease.
W C, Thornbury, P, Aaron
openaire +1 more source
The nature of Vicia faba alpha-galactosidases
1983Two molecular forms I and II (separable by gel filtration) from mature Vicia faba seeds have been studied. The extractability of the enzymes and the in vitro conversion of the low MW form, II, to the larger oligomer, I has been examined over a range of salt concentrations.
openaire +1 more source

